Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.
Smith MR, Lee H, Fallon MA, Nathan DM. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology. 2008 Feb; 71(2):318-22.